Cargando…

564. SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus Immunogenicity

BACKGROUND: The zoonotic emergence of SARS-CoV-2 quickly developed into a global pandemic. Multiple vaccine platforms have been advanced to clinical trials and emergency use authorization. The recent emergence of SARS-CoV-2 virus variants with Spike receptor-binding domain (RBD) and N-terminal domai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joyce, M G, Chen, Wei-Hung, Sankhala, Rajeshwer, Hajduczki, Agnes, Thomas, Paul, Martinez, Elizabeth, Peterson, Caroline, Rao, Mangala, Modjarrad, Kayvon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644205/ http://dx.doi.org/10.1093/ofid/ofab466.762

Ejemplares similares

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
por: Joyce, M. Gordon, et al.
Publicado: (2021)

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
por: Joyce, M. Gordon, et al.
Publicado: (2021)

SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses
por: Carmen, Joshua M., et al.
Publicado: (2021)

A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein
por: Joyce, M. Gordon, et al.
Publicado: (2020)

SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies
por: Shrivastava, Shikha, et al.
Publicado: (2023)

A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model
por: Johnston, Sara C., et al.
Publicado: (2022)

Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
por: Chen, Wei-Hung, et al.
Publicado: (2023)

A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge
por: Wuertz, Kathryn McGuckin, et al.
Publicado: (2021)

Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques
por: Yu, Jingyou, et al.
Publicado: (2023)

Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks
por: Joyce, M. Gordon, et al.
Publicado: (2020)

Treatment strategies for Middle East respiratory syndrome coronavirus
por: Modjarrad, Kayvon
Publicado: (2016)

A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters
por: Wuertz, Kathryn McGuckin, et al.
Publicado: (2021)

554. A Candidate SARS-Associated Coronavirus Vaccine Elicits Broad Immunity in Monkeys
Publicado: (2004)

A comparative recombination analysis of human coronaviruses and implications for the SARS-CoV-2 pandemic
por: Pollett, Simon, et al.
Publicado: (2021)

Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?
por: Modjarrad, Kayvon, et al.
Publicado: (2020)

Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants
por: Balasubramaniyam, Arasu, et al.
Publicado: (2022)

HIV and SARS-CoV-2: Tracing a Path of Vaccine Research and Development
por: Shepherd, Brittany Ober, et al.
Publicado: (2022)

Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (S) proteins
por: Zhou, Peng, et al.
Publicado: (2009)

MERS-CoV vaccine candidates in development: The current landscape
por: Modjarrad, Kayvon
Publicado: (2016)

Immunogenicity of the spike glycoprotein of Bat SARS-like coronavirus
por: Hou, Yu-xuan, et al.
Publicado: (2010)

Correlation of Membrane Binding and Hydrophobicity to the Chaperone-Like Activity of PDC-109, the Major Protein of Bovine Seminal Plasma
por: Sankhala, Rajeshwer S., et al.
Publicado: (2011)

56.4 Accomplishing Change in This Digital World
por: Krakower, Scott
Publicado: (2022)

Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
por: Kapingidza, A. Brenda, et al.
Publicado: (2023)

A broad and potent neutralization epitope in SARS-related coronaviruses
por: Yuan, Meng, et al.
Publicado: (2022)

A broad and potent neutralization epitope in SARS-related coronaviruses
por: Yuan, Meng, et al.
Publicado: (2022)

Stabilized coronavirus spike stem elicits a broadly protective antibody
por: Hsieh, Ching-Lin, et al.
Publicado: (2021)

Structure of Human PIR1, an Atypical Dual-Specificity Phosphatase
por: Sankhala, Rajeshwer Singh, et al.
Publicado: (2014)

Multiple co-circulating HIV-1 subtypes in the Middle East and North Africa
por: Rolland, Morgane, et al.
Publicado: (2015)

Identification of immunogenic determinants of the spike protein of SARS-like coronavirus
por: Zhou, Peng, et al.
Publicado: (2013)

Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
por: King, Hannah A. D., et al.
Publicado: (2021)

Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
por: Dussupt, Vincent, et al.
Publicado: (2021)

KEYNOTE-564: Adjuvant immunotherapy for renal cell carcinoma
por: Pandey, Abhishek
Publicado: (2022)

564. Nocardiosis in Portugal: a single-center experience
por: Besteiro, Bruno, et al.
Publicado: (2023)

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
por: Weidenbacher, Payton A.-B., et al.
Publicado: (2022)

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
por: Weidenbacher, Payton A.-B., et al.
Publicado: (2023)

Ensuring HIV Data Availability, Transparency and Integrity in the MENA Region: Comment on "Improving the Quality and Quantity of HIV Data in the Middle East and North Africa: Key Challenges and Ways Forward"
por: Modjarrad, Kayvon, et al.
Publicado: (2017)

Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology
por: Hills, Rory A., et al.
Publicado: (2023)

SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2022)

Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2
por: Luo, Mengxiao, et al.
Publicado: (2023)

A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice
por: Powell, Abigail E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bam27h0ofqlf62lv1k06fdfbss